Clinical tests

Enrollment phase of INDYGO is now successfully achieved

After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial

Rare diseases foundation and OncoThAI

OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord

Photodynamic Therapy and OncoThAI illustrated in Nature journal

The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal

Authorizations for the PAGETEX clinical trial

 The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.

End of the evaluation of the PHOSISTOS® project

Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission

Start of the PAGETEX clinical trial

The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.

Back